HKSE - Delayed Quote HKD

Gushengtang Holdings Limited (2273.HK)

Compare
32.050
+0.550
+(1.75%)
At close: 4:08:14 PM GMT+8
Loading Chart for 2273.HK
  • Previous Close 31.500
  • Open 30.900
  • Bid 31.900 x --
  • Ask 32.050 x --
  • Day's Range 30.550 - 32.150
  • 52 Week Range 25.500 - 49.900
  • Volume 3,533,800
  • Avg. Volume 3,948,277
  • Market Cap (intraday) 7.622B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 24.47
  • EPS (TTM) 1.310
  • Earnings Date --
  • Forward Dividend & Yield 0.82 (2.60%)
  • Ex-Dividend Date Jun 24, 2025
  • 1y Target Est 52.65

Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People's Republic of China. The company offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. It is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. Gushengtang Holdings Limited was founded in 2010 and is headquartered in Guangzhou, the People's Republic of China.

www.gstzy.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2273.HK

View More

Performance Overview: 2273.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2273.HK
4.04%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

2273.HK
26.98%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

2273.HK
5.53%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

2273.HK
4.04%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 2273.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2273.HK

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    7.49B

  • Enterprise Value

    6.81B

  • Trailing P/E

    24.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.44

  • Price/Book (mrq)

    2.94

  • Enterprise Value/Revenue

    2.10

  • Enterprise Value/EBITDA

    16.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.15%

  • Return on Assets (ttm)

    5.99%

  • Return on Equity (ttm)

    13.12%

  • Revenue (ttm)

    3.02B

  • Net Income Avi to Common (ttm)

    306.78M

  • Diluted EPS (ttm)

    1.310

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.15B

  • Total Debt/Equity (mrq)

    21.40%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2273.HK

View More

Company Insights: 2273.HK

Research Reports: 2273.HK

View More

People Also Watch